Gain Therapeutics Inc (GANX)

Dec 10, 2025

Gain Therapeutics At A Crossroads: Will GT-02287 Deliver Disease-Modifying Proof? - RTTNews

Dec 10, 2025

Dec 10, 2025

How sustainable is Gain Therapeutics Inc stock dividend payoutProfit Target & Consistent Growth Equity Picks - BỘ NỘI VỤ

Dec 10, 2025

Dec 08, 2025

Gain Therapeutics Inc (GANX) expanding its growth trajectory ahead - Setenews

Dec 08, 2025

Dec 08, 2025

Here's Why Gain Therapeutics, Inc. (GANX) is a Great Momentum Stock to Buy - Yahoo Finance

Dec 08, 2025

Dec 08, 2025

Gain Therapeutics, Inc. (NASDAQ:GANX) Receives Average Rating of “Moderate Buy” from Analysts - Defense World

Dec 08, 2025

Dec 06, 2025

Winners Losers: Is Gain Therapeutics Inc stock a smart buy before Fed meeting2025 Volume Leaders & Fast Momentum Stock Entry Tips - BỘ NỘI VỤ

Dec 06, 2025

Dec 06, 2025

Gain Therapeutics Announces New Stock Offering Program - MSN

Dec 06, 2025

Dec 04, 2025

Gain Therapeutics, Inc. (GANX) 5.14% in After-hours: What’s Driving the Move? - Stocks Telegraph

Dec 04, 2025

Dec 04, 2025

Levels Update: Will Repare Therapeutics Inc. stock gain from lower inflation2025 AllTime Highs & Expert Verified Movement Alerts - BỘ NỘI VỤ

Dec 04, 2025

Dec 04, 2025

FY2025 Earnings Forecast for GANX Issued By HC Wainwright - MarketBeat

Dec 04, 2025

Dec 04, 2025

HC Wainwright Predicts Higher Earnings for Gain Therapeutics - Defense World

Dec 04, 2025

Dec 02, 2025

H.C. Wainwright reiterates Buy rating on Gain Therapeutics stock ahead of trial data By Investing.com - Investing.com South Africa

Dec 02, 2025

Dec 01, 2025

Gain Therapeutics (GANX) Stock Analysis Report | Financials & Insights - Benzinga

Dec 01, 2025

Dec 01, 2025

H.C. Wainwright reiterates Buy rating on Gain Therapeutics stock ahead of trial data - Investing.com Canada

Dec 01, 2025

Nov 30, 2025

Gain Therapeutics’ (GANX) Preclinical Momentum Drives Its Progress in Parkinson’s Drug Development - MSN

Nov 30, 2025

Nov 29, 2025

What drives Gain Therapeutics Inc stock priceGrowth vs. Value Investing & Low Cost Market Strategies - earlytimes.in

Nov 29, 2025

Nov 29, 2025

Gain Therapeutics files prospectus supplement for $35.5 million stock offering By Investing.com - Investing.com Australia

Nov 29, 2025

Nov 29, 2025

Gain Therapeutics' (GANX) Preclinical Momentum Drives Its Progress in Parkinson's Drug Development - Finviz

Nov 29, 2025

Nov 28, 2025

Gain Therapeutics files prospectus supplement for $35.5 million stock offering - Investing.com

Nov 28, 2025

Nov 28, 2025

Gain Therapeutics files prospectus for $35.5 million stock saleSEC filing - marketscreener.com

Nov 28, 2025

Nov 28, 2025

Gain Therapeutics Files Prospectus Supplement for Stock Offering - TradingView

Nov 28, 2025

Nov 27, 2025

Can Gain Therapeutics Inc. stock sustain institutional interestTrend Reversal & Smart Allocation Stock Reports - BỘ NỘI VỤ

Nov 27, 2025

Nov 27, 2025

12 Hot Penny Stocks to Invest in Right Now - Insider Monkey

Nov 27, 2025

Nov 27, 2025

Valuation Update: Why Gain Therapeutics Inc. stock could see breakout soonNew Guidance & Daily Technical Stock Forecast Reports - moha.gov.vn

Nov 27, 2025

Nov 24, 2025

A History of Outperforming Analyst Forecasts and Beating the Odds: Gain Therapeutics Inc (GANX) - Setenews

Nov 24, 2025

Nov 24, 2025

Gain Therapeutics Inc Stock Analysis and ForecastRisk-Reward Ratio Analysis & Rapid Wealth Building Tips - earlytimes.in

Nov 24, 2025

Nov 21, 2025

How Gain Therapeutics Inc. stock compares to industry benchmarksWeekly Profit Report & Expert Approved Trade Ideas - newser.com

Nov 21, 2025

Nov 20, 2025

Gain Therapeutics presents data on GT-02287 - TipRanks

Nov 20, 2025

Nov 20, 2025

Gain Therapeutics Presents Preclinical GT-02287 Data at Neuroscience 2025 - The Manila Times

Nov 20, 2025

Nov 20, 2025

Gain Therapeutics (Nasdaq: GANX) Reports GT-02287 Mitochondrial, Neuronal Data - Stock Titan

Nov 20, 2025

Nov 20, 2025

Will Gain Therapeutics Inc. stock deliver strong dividend growthInsider Buying & Real-Time Volume Analysis Alerts - newser.com

Nov 20, 2025

Nov 19, 2025

Gain Therapeutics Inc. stock outlook for YEARJuly 2025 Short Interest & Risk Controlled Swing Alerts - newser.com

Nov 19, 2025

Nov 19, 2025

Is Gain Therapeutics Inc. stock ready for a breakoutWeekly Trade Recap & Weekly Breakout Watchlists - newser.com

Nov 19, 2025

Nov 19, 2025

Can machine learning forecast Gain Therapeutics Inc. recovery2025 Performance Recap & Fast Momentum Entry Tips - newser.com

Nov 19, 2025

Nov 17, 2025

Gain Therapeutics (GANX) Upgraded to Buy: Here's What You Should Know - sharewise.com

Nov 17, 2025

Nov 17, 2025

How does Gain Therapeutics Inc (GANX) change from a tortoise to a hare? - Setenews

Nov 17, 2025

Nov 17, 2025

Is Gain Therapeutics Inc. stock undervalued vs historical averagesQuarterly Market Summary & Consistent Growth Stock Picks - newser.com

Nov 17, 2025

Nov 17, 2025

Equities Analysts Set Expectations for GANX FY2025 Earnings - MarketBeat

Nov 17, 2025

Nov 17, 2025

Will Gain Therapeutics Inc. stock go up soon2025 Price Targets & AI Enhanced Trading Signals - newser.com

Nov 17, 2025

Nov 16, 2025

Can Gain Therapeutics Inc. stock deliver sustainable ROEWeekly Trade Summary & AI Enhanced Trade Execution Alerts - newser.com

Nov 16, 2025

Nov 16, 2025

Why Gain Therapeutics Inc. stock remains on buy listsJuly 2025 Sector Moves & Free Safe Capital Growth Stock Tips - newser.com

Nov 16, 2025